Elanco Animal Health (NYSE: ELAN) reported Q1 EPS of $0.13, $0.10 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $657.7 million versus the consensus estimate of $714.97 million.

• Long-term industry fundamentals remain intact; 2020 guidance withdrawn due to uncertainty of the duration and magnitude of impacts from the COVID-19 pandemic.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.